Avantra Family Wealth Inc. Makes New $279,000 Investment in Humana Inc. (NYSE:HUM)

Avantra Family Wealth Inc. purchased a new position in Humana Inc. (NYSE:HUM - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,053 shares of the insurance provider's stock, valued at approximately $279,000.

Several other hedge funds have also added to or reduced their stakes in the business. Manning & Napier Advisors LLC lifted its stake in Humana by 92.4% in the first quarter. Manning & Napier Advisors LLC now owns 13,387 shares of the insurance provider's stock worth $3,542,000 after purchasing an additional 6,430 shares during the last quarter. Sivik Global Healthcare LLC lifted its stake in Humana by 15.0% in the first quarter. Sivik Global Healthcare LLC now owns 23,000 shares of the insurance provider's stock worth $6,086,000 after purchasing an additional 3,000 shares during the last quarter. Garde Capital Inc. bought a new stake in Humana in the first quarter worth $36,000. Canoe Financial LP raised its stake in shares of Humana by 131.3% during the first quarter. Canoe Financial LP now owns 562 shares of the insurance provider's stock valued at $149,000 after acquiring an additional 319 shares during the last quarter. Finally, Osborne Partners Capital Management LLC raised its stake in shares of Humana by 0.5% during the first quarter. Osborne Partners Capital Management LLC now owns 21,651 shares of the insurance provider's stock valued at $5,729,000 after acquiring an additional 117 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Guggenheim assumed coverage on shares of Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective for the company. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a research note on Thursday, May 1st. Truist Financial set a $280.00 price objective on shares of Humana and gave the company a "hold" rating in a research note on Tuesday, June 17th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price objective on shares of Humana in a research note on Thursday, May 1st. Finally, Oppenheimer upped their price objective on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Seventeen analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Humana currently has a consensus rating of "Hold" and a consensus price target of $280.76.

Humana Price Performance

Shares of HUM opened at $239.66 on Friday. The stock has a market cap of $28.92 billion, a PE ratio of 16.95, a price-to-earnings-growth ratio of 1.81 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91. Humana Inc. has a fifty-two week low of $212.45 and a fifty-two week high of $406.46. The firm's 50-day simple moving average is $245.76 and its two-hundred day simple moving average is $260.83.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The business had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.42% and a return on equity of 14.47%. The business's revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $7.23 earnings per share. Analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.